3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 1/2
1
Status
Recruiting
3
Withdrawn
1
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Prostatic Neoplasms
32
Brain Neoplasms
21
Carcinoma, Non-Small-Cell Lung
19
Neoplasm Metastasis
17
Lung Neoplasms
15
Carcinoma, Hepatocellular
13
Breast Neoplasms
10
Pancreatic Neoplasms
9
Melanoma
9
Carcinoma, Renal Cell
9
Neoplasms
7
Colorectal Neoplasms
7
Spinal Cord Neoplasms
3
Small Cell Lung Carcinoma
3
Prostate Cancer Metastatic
3
Nasopharyngeal Carcinoma
3
Kidney Neoplasms
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Unresectable Locally Recurrent Rectal Cancer
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Radiation Injuries
2
Osteosarcoma
2
Oligometastatic Prostate Cancer
2
Neuroma, Acoustic
2
Neoplasms by Site
2
Klatskin Tumor
2
Head and Neck Neoplasms
2
Interventions
Radiosurgery
3
Androgen Antagonists
3
pembrolizumab
1
fludrocortisone acetate
1
enzalutamide
1
darolutamide
1
cabazitaxel
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Prednisone
1
Pluvicto
1
Lutetium-177
1
Lutetium
1
Hydrocortisone
1
Gonadotropin-Releasing Hormone
1
Docetaxel
1
Dexamethasone
1
Carboplatin
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Prostate Cancer Metastatic
×
Radiosurgery
×
Clear all
NCT04983095
2026-02-17
METRO
Umeå University
Phase NA
Recruiting
118 enrolled
NCT06320067
2025-09-26
STAMPEDE2
University College, London
Phase 3
Recruiting
3,360 enrolled
NCT04086290
2020-02-12
Oligomet_DK
Herlev Hospital
Phase 1/2
Recruiting
20 enrolled